Drive engagement, advance care, and improve patient outcomes with a clinically-rich registry that achieves measurable quality improvement and impactful research.
Create a patient-centric research registry that identifies research priorities, accelerates discovery and therapeutic development, measures outcomes, and empowers patient decision making.
Transform real-world data from disparate sources into a central source of truth: reliable, real-world evidence for post-market surveillance, and registry-based research and clinical trials.
Deliver high value care, simplify and accelerate your participation in value-based payment models, and chart your own course as you take on risk.
RegistryX, our clinical registry software, transforms healthcare data into clinically-rich and relevant evidence that delivers the precise insights you need to measure and improve clinical outcomes, advance research, and demonstrate safety, effectiveness, and value.
"There isn’t any question that our partnership with ArborMetrix has been the major driver in getting the collaborative to where we are today. Through their platform, we have achieved a significant reduction in cardiac surgical mortality in children."
Executive Director, Pediatric Cardiac Critical Care Consortium; Co-Director, Cardiac Networks United
“Creating an infrastructure that is both innovative and nimble in supporting our needs is critical to the success of the registry and our specialty. ArborMetrix has the solutions and expertise to help us meet our goals.”
Chair, AAPM&R Registry Steering Committee
Advance care and treatments, reduce adverse events, and improve guideline adherence with credible, evidence-based insights that drive measurable quality improvement.
Leverage high-quality, research-grade data and analytics to accelerate scientific and clinical research, and encourage deeper investigation into clinical trends and outcomes.
Advance advocacy efforts with real-world evidence that accelerates research, empowers patient decision-making, and enhances your community’s data asset.
Optimize participation in risk-based arrangements and alternative payment models by monitoring and managing the complete costs and quality of episodes of care.
Support post-market studies, and registry-enhanced or registry-based clinical trials, by leveraging high-quality, research-grade data and proven analytics.
